QI
ONC

QS Investors’s BeOne Medicines Ltd ONC Stock Holding History

QS Investors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$618K Hold
1,800
– – 0.01% 651
2021
Q1 		$627K Sell
1,800
-100
-5% -$33.1K 0.01% 700
2020
Q4 		$491K Buy
+1,900
New +$523K 0.01% 797
2019
Q2 		– Sell
-1,032
Closed -$137K – 1686
2019
Q1 		$137K Sell
1,032
-290
-22% -$39.1K ﹤0.01% 1327
2018
Q4 		$186K Buy
+1,322
New +$175K ﹤0.01% 1149

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QS Investors's ONC Position: Q2 2021 in Review

QS Investors held its BeOne Medicines Ltd (ONC) position steady in Q2 2021 at 1,800 shares worth $618K. The position accounts for 0.01% of the portfolio, ranked #651.

QS Investors first reported a position in ONC in Q4 2018 and has held it in 5 quarters since. The position peaked at $627K in Q1 2021. 267 funds tracked by Wall St. Rank hold ONC as of Q2 2021.

  • QS Investors held 1,800 shares of BeOne Medicines Ltd worth $618K as of Q2 2021.
  • QS Investors left its BeOne Medicines Ltd share count unchanged in Q2 2021.
  • BeOne Medicines Ltd made up 0.01% of QS Investors's portfolio in Q2 2021, its #651 holding.
  • QS Investors first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 5 quarters since.
  • QS Investors's BeOne Medicines Ltd position peaked at $627K in Q1 2021.
  • 267 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.